Journal articles: 'Transfeminine'

1

Raha, Nat. "Transfeminine Brokenness, Radical Transfeminism." South Atlantic Quarterly 116, no. 3 (July 2017): 632–46. http://dx.doi.org/10.1215/00382876-3961754.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Adair, Cassius. "Solidarity in the Centerfold." Feminist Media Histories 9, no. 1 (January 1, 2023): 52–77. http://dx.doi.org/10.1525/fmh.2023.9.1.52.

Full text

Abstract:

This essay argues that certain print pornography featuring “crossdresser,” “transvestite,” and “transsexual” subjects was, counterintuitively, part of a distributed information and care network by and for US transfeminine people between the 1970s and 1990s. While this genre of “transploitation” magazine did reproduce transfeminine bodies as fetish objects, transfeminine individuals themselves also used the adult magazine and bookstore market to distribute clandestine information on hormonal, sartorial, and social self-fashioning and support. This symbiotic relationship with the pornographic allowed information about transfeminity to circulate to individuals with little economic means as well as to reach people who did not have regional or cultural access to the respectable “CD,” “TV,” or “TS” community media of the era. In this way, these magazines formed part of a social safety network: a shadow system of circulating subcultural knowledges within mainstream media in order to survive legal censorship, medical exclusion, and economic abandonment.

APA, Harvard, Vancouver, ISO, and other styles

3

Gentile, Jill. "TransFeminine law." International Journal of Psychoanalysis 102, no. 5 (September 3, 2021): 1001–3. http://dx.doi.org/10.1080/00207578.2021.1970317.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Houle, Nichole, and Susannah V. Levi. "Gender expression in productions of /s/ and /ʃ/." Journal of the Acoustical Society of America 153, no. 3_supplement (March 1, 2023): A367. http://dx.doi.org/10.1121/10.0019185.

Full text

Abstract:

The spectral features of /s/ and /ʃ/ carry important sociophonetic information regarding a speaker’s gender. Gender is defined as man or woman, but this excludes people who identify as trans and gender non-conforming. In this study, we use a more expansive definition of gender to investigate the acoustics (duration and spectral moments) of /s/ and /ʃ/ across cis men, cis women, and transfeminine speakers in voiced and whispered speech. Additionally, we investigated the relationship between spectral measures and transfeminine gender expression. We examined /s/ and /ʃ/ productions in words from 30 speakers (10 cis men, 14 cis women, and 6 transfeminine) and 31 speakers (10 cis men, 13 cis women, and 8 transfeminine), respectively. In general, fricative center of gravity was highest in productions by cis women, followed by transfeminine, and then cis men speakers. Gender differences were found for /s/, but not /ʃ/. Cis women speakers produced /s/ with greater negative skew than cis men speakers. Transfeminine speakers did not differ from either group. Within transfeminine speakers, /s/ and /ʃ/ center of gravity were related to a speaker’s gender related voice concerns. Taken together, /s/ and /ʃ/ differed by gender and may be related to transfeminine vocal concerns.

APA, Harvard, Vancouver, ISO, and other styles

5

Houle, Nichole, Mackenzie P. Lerario, and Susannah V. Levi. "Spectral analysis of strident fricatives in cisgender and transfeminine speakers." Journal of the Acoustical Society of America 154, no. 5 (November 1, 2023): 3089–100. http://dx.doi.org/10.1121/10.0022387.

Full text

Abstract:

The spectral features of /s/ and /ʃ/ carry important sociophonetic information regarding a speaker's gender. Often, gender is misclassified as a binary of male or female, but this excludes people who may identify as transgender or nonbinary. In this study, we use a more expansive definition of gender to investigate the acoustics (duration and spectral moments) of /s/ and /ʃ/ across cisgender men, cisgender women, and transfeminine speakers in voiced and whispered speech and the relationship between spectral measures and transfeminine gender expression. We examined /s/ and /ʃ/ productions in words from 35 speakers (11 cisgender men, 17 cisgender women, 7 transfeminine speakers) and 34 speakers (11 cisgender men, 15 cisgender women, 8 transfeminine speakers), respectively. In general, /s/ and /ʃ/ center of gravity was highest in productions by cisgender women, followed by transfeminine speakers, and then cisgender men speakers. There were no other gender-related differences. Within transfeminine speakers, /s/ and /ʃ/ center of gravity and skewness were not related to the time proportion expressing their feminine spectrum gender or their Trans Women Voice Questionnaire scores. Taken together, the acoustics of /s/ and /ʃ/ may signal gender group identification but may not account for within-gender variation in transfeminine gender expression.

APA, Harvard, Vancouver, ISO, and other styles

6

Hamidi, Oksana, and Caroline J. Davidge-Pitts. "Transfeminine Hormone Therapy." Endocrinology and Metabolism Clinics of North America 48, no. 2 (June 2019): 341–55. http://dx.doi.org/10.1016/j.ecl.2019.02.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Walls, N. Eugene, Shanna K. Kattari, Stephanie Rachel Speer, and M. Killian Kinney. "Transfeminine Spectrum Parenting: Evidence from the National Transgender Discrimination Survey." Social Work Research 43, no. 3 (March 30, 2019): 133–44. http://dx.doi.org/10.1093/swr/svz005.

Full text

Abstract:

Abstract Using data from the 2010 National Transgender Discrimination Survey, authors examined differences in likelihood of being a parent across a number of factors and described parenting experiences of those who were assigned a male sex at birth (AMAB) and who currently identify on the transfeminine spectrum (AMAB-transfeminine). Authors found that those who are AMAB-genderqueer are more likely to be parents, while those who were assigned female at birth regardless of gender identity are less likely to be parents. Among AMAB-transfeminine individuals, increases in likelihood of being a parent were found based on Latinx racial identity, being in a relationship, and with increases in age and income, whereas no significant differences were found based on educational level or disability status. Equal proportions of the AMAB-transfeminine parents reported that their relationship with their children has either stayed the same or become worse since coming out and between 16.0% and 42.0% of AMAB-transfeminine parents reported that either a judge, their ex-partner, or their children have limited their relationship. Findings underscore the importance of an intersectional understanding of the transgender community and the need for intersectional cultural responsiveness training for social workers, along with the need for family interventions and policy advocacy work.

APA, Harvard, Vancouver, ISO, and other styles

8

Merritt, Brandon, and Tessa Bent. "Perceptual Evaluation of Speech Naturalness in Speakers of Varying Gender Identities." Journal of Speech, Language, and Hearing Research 63, no. 7 (July 17, 2020): 2054–69. http://dx.doi.org/10.1044/2020_jslhr-19-00337.

Full text

Abstract:

Purpose The purpose of this study was to investigate how speech naturalness relates to masculinity–femininity and gender identification (accuracy and reaction time) for cisgender male and female speakers as well as transmasculine and transfeminine speakers. Method Stimuli included spontaneous speech samples from 20 speakers who are transgender (10 transmasculine and 10 transfeminine) and 20 speakers who are cisgender (10 male and 10 female). Fifty-two listeners completed three tasks: a two-alternative forced-choice gender identification task, a speech naturalness rating task, and a masculinity/femininity rating task. Results Transfeminine and transmasculine speakers were rated as significantly less natural sounding than cisgender speakers. Speakers rated as less natural took longer to identify and were identified less accurately in the gender identification task; furthermore, they were rated as less prototypically masculine/feminine. Conclusions Perceptual speech naturalness for both transfeminine and transmasculine speakers is strongly associated with gender cues in spontaneous speech. Training to align a speaker's voice with their gender identity may concurrently improve perceptual speech naturalness. Supplemental Material https://doi.org/10.23641/asha.12543158

APA, Harvard, Vancouver, ISO, and other styles

9

Ellis, Simon Adriane, and Lily Dalke. "Midwifery Care for Transfeminine Individuals." Journal of Midwifery & Women's Health 64, no. 3 (April 8, 2019): 298–311. http://dx.doi.org/10.1111/jmwh.12957.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Abramowitz, Jessica, and Vin Tangpricha. "Hormonal Management for Transfeminine Individuals." Clinics in Plastic Surgery 45, no. 3 (July 2018): 313–17. http://dx.doi.org/10.1016/j.cps.2018.03.003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Pihlak, Chris Aino. "How Transgressive a Transsexual? The Contradictions in Transgression and Conformity Within Transfeminine Print Erotica." Graduate History Review 11, no. 1 (September 22, 2022): 107–45. http://dx.doi.org/10.18357/ghr111202220526.

Full text

Abstract:

Mainstream transfeminine porn was the central element shaping mid-century American cultural understandings of transness. Despite this representational importance, the study of transfeminine erotica is a niche field. This paper helps fill this gap via analysis of eighty-six issues of erotica from the late 1960s to early 1980s. Pihlak demonstrates the contradictions in transfeminine desirability in these works. Despite overwhelming bodily normativity, the presence of a penis invariably led to models being framed as lurid, transgressive erotic objects. Pihlak’s findings demonstrate the insufficiency of the concept of normativity. Then and now, the smallest breach to normative white cisfemininity renders one’s claim to womanhood unstable. While this instability has material consequences for trans femmes, for many this precarity is solely an alluring invitation, to take a walk on the wild side.

APA, Harvard, Vancouver, ISO, and other styles

12

DeVito, Michael Ann. "How Transfeminine TikTok Creators Navigate the Algorithmic Trap of Visibility Via Folk Theorization." Proceedings of the ACM on Human-Computer Interaction 6, CSCW2 (November 7, 2022): 1–31. http://dx.doi.org/10.1145/3555105.

Full text

Abstract:

Social platforms open important doors to visibility for transgender people, through which they can pursue key goals such as broader recognition and normalization. However, each door is also potentially a trap, filled with risks and consequences - especially for those whose goals require visibility. Via a grounded theory interview study with 17 transfeminine content creators on TikTok, I find that, in an algorithmically mediated environment such as TikTok, users navigate potential doors to visibility and their associated traps via folk theorization. Moreover, I find that transfeminine creators employ multiple complex and overlapping folk theories, with actionable theories guiding the careful navigation of doors to visibility, and demotivational theories alerting creators to traps that are too risky to spring. I introduce five novel folk theories of TikTok spanning both the For You Page and content moderation systems which creators use to guide their decision making, and discuss how two cross-cutting issues, perceived algorithmic paternalism and decontextualization, illustrate major issues for transfeminine creators and opportunities for more supportive design.

APA, Harvard, Vancouver, ISO, and other styles

13

Islam, Noreen, Rebecca Nash, Qi Zhang, Leonidas Panagiotakopoulos, Tanicia Daley, Shalender Bhasin, Darios Getahun, et al. "Is There a Link Between Hormone Use and Diabetes Incidence in Transgender People? Data From the STRONG Cohort." Journal of Clinical Endocrinology & Metabolism 107, no. 4 (November 23, 2021): e1549-e1557. http://dx.doi.org/10.1210/clinem/dgab832.

Full text

Abstract:

Abstract Background Risk of type 2 diabetes mellitus (T2DM) in transgender and gender diverse (TGD) persons, especially those receiving gender-affirming hormone therapy (GAHT) is an area of clinical and research importance. Methods We used data from an electronic health record-based cohort study of persons 18 years and older enrolled in 3 integrated health care systems. The cohort included 2869 transfeminine members matched to 28 300 cisgender women and 28 258 cisgender men on age, race/ethnicity, calendar year, and site, and 2133 transmasculine members similarly matched to 20 997 cisgender women and 20 964 cisgender men. Cohort ascertainment spanned 9 years from 2006 through 2014 and follow-up extended through 2016. Data on T2DM incidence and prevalence were analyzed using Cox proportional hazards and logistic regression models, respectively. All analyses controlled for body mass index. Results Both prevalent and incident T2DM was more common in the transfeminine cohort relative to cisgender female referents with odds ratio and hazard ratio (95% CI) estimates of 1.3 (1.1-1.5) and 1.4 (1.1-1.8), respectively. No significant differences in prevalence or incidence of T2DM were observed across the remaining comparison groups, both overall and in TGD persons with evidence of GAHT receipt. Conclusion Although transfeminine people may be at higher risk for T2DM compared with cisgender females, the corresponding difference relative to cisgender males is not discernable. Moreover, there is little evidence that T2DM occurrence in either transfeminine or transmasculine persons is attributable to GAHT use.

APA, Harvard, Vancouver, ISO, and other styles

14

Jackson, Sarah S., Jalen Brown, Ruth M. Pfeiffer, Duncan Shrewsbury, Stewart O’Callaghan, Alison M. Berner, Shahinaz M. Gadalla, and Meredith S. Shiels. "Analysis of Mortality Among Transgender and Gender Diverse Adults in England." JAMA Network Open 6, no. 1 (January 30, 2023): e2253687. http://dx.doi.org/10.1001/jamanetworkopen.2022.53687.

Full text

Abstract:

ImportanceLimited prior research suggests that transgender and gender diverse (TGD) people may have higher mortality rates than cisgender people.ObjectiveTo estimate overall and cause-specific mortality among TGD persons compared with cisgender persons.Design, Setting, and ParticipantsThis population-based cohort study used data from general practices in England contributing to the UK’s Clinical Practice Research Datalink GOLD and Aurum databases. Transfeminine (assigned male at birth) and transmasculine (assigned female at birth) individuals were identified using diagnosis codes for gender incongruence, between 1988 and 2019, and were matched to cisgender men and women according to birth year, practice, and practice registration date and linked to the Office of National Statistics death registration. Data analysis was performed from February to June 2022.Main Outcomes and MeasuresCause-specific mortality counts were calculated for categories of disease as defined by International Statistical Classification of Diseases and Related Health Problems, Tenth Revision chapters. Overall and cause-specific mortality rate ratios (MRRs) were estimated using Poisson models, adjusted for index age, index year, race and ethnicity, Index of Multiple Deprivation, smoking status, alcohol use, and body mass index.ResultsA total of 1951 transfeminine (mean [SE] age, 36.90 [0.34] years; 1801 White [92.3%]) and 1364 transmasculine (mean [SE] age, 29.20 [0.36] years; 1235 White [90.4%]) individuals were matched with 68 165 cisgender men (mean [SE] age, 33.60 [0.05] years; 59 136 White [86.8%]) and 68 004 cisgender women (mean [SE] age, 33.50 [0.05] years; 57 762 White [84.9%]). The mortality rate was 528.11 deaths per 100 000 person-years (102 deaths) for transfeminine persons, 325.86 deaths per 100 000 person-years (34 deaths) for transmasculine persons, 315.32 deaths per 100 000 person-years (1951 deaths) for cisgender men, and 260.61 deaths per 100 000 person-years (1608 deaths) for cisgender women. Transfeminine persons had a higher overall mortality risk compared with cisgender men (MRR, 1.34; 95% CI, 1.06-1.68) and cisgender women (MRR, 1.60; 95% CI, 1.27-2.01). For transmasculine persons, the overall MMR was 1.43 (95% CI, 0.87-2.33) compared with cisgender men and was 1.75 (95% CI, 1.08-2.83) compared with cisgender women. Transfeminine individuals had lower cancer mortality than cisgender women (MRR, 0.52; 95% CI, 0.32-0.83) but an increased risk of external causes of death (MRR, 1.92; 95% CI, 1.05-3.50). Transmasculine persons had higher mortality from external causes of death than cisgender women (MRR, 2.77; 95% CI, 1.15-6.65). Compared with cisgender men, neither transfeminine nor transmasculine adults had a significantly increased risk of deaths due to external causes.Conclusions and RelevanceIn this cohort study of primary care data, TGD persons had elevated mortality rates compared with cisgender persons, particularly for deaths due to external causes. Further research is needed to examine how minority stress may be contributing to deaths among TGD individuals to reduce mortality.

APA, Harvard, Vancouver, ISO, and other styles

15

Restar, Arjee J., Aaron S. Breslow, Harry Jin, Ma Irene Quilantang, Olivia Sison, Amiel Nazer Bermudez, Maylin Palatino, et al. "Transgender-specific developmental milestones and associated experiences of violence, discrimination, and stigma among Filipinx transgender women who are sexually active with men." PLOS ONE 16, no. 3 (March 9, 2021): e0248248. http://dx.doi.org/10.1371/journal.pone.0248248.

Full text

Abstract:

Background For transgender people, reaching transgender (trans)-specific developmental milestones, including recognizing and expressing one’s identity, plays an integral role in overall health, wellbeing, and the pursuit of gender affirmation. Yet trans people continue to face minority stressors, including structural violence (i.e., discrimination, violence, and stigma), which may interfere with the achievement of these milestones. Among trans women specifically, however, potential associations between gender developmental milestones and structural violence are not well characterized in the literature. In a sample of Filipinx (i.e., an inclusive term for describing non-binary genders in the Philippines) trans women who are sexually active with men (trans-WSM), we thus sought to: (a) describe the mean ages at which gender developmental milestones occur and (b) examine the associations between structural violence and mean ages at which at which Filipinx trans-WSM experience trans-specific developmental milestones. Methods Using data from Project #ParaSaAtin, an online survey of Filipinx trans-WSM (n = 139), we mapped age-estimates per trans-specific milestones and then tested whether structural violence is associated with the mean age at which trans women experience trans-specific developmental milestones. Results Overall, participants who reported higher levels of discrimination, stigma, and violence also experienced a later age for nearly each milestone (i.e., initial self-awareness of transfeminine identity, transfeminine expression in private, transfeminine expression in public, first consensual oral/vaginal/anal sex with a cisgender male partner, first consensual oral/vaginal/anal sex with a cisgender male partner as a trans women, and hormone integration) (all p-values <0.05). Of note, the single exception to this pattern was the non-significant association between stigma and initial disclosure of transfeminine identification to another person. Conclusion Results are consistent with psychological literature outlining a temporal sequence of developmental milestones among young trans-WSM. For young trans-WSM in the Philippines, data from this study demonstrate significant associations between structural violence and the achievement of developmental milestones. These findings highlight the need for trauma-informed, strengths-based programming and institutional policies that measure and mitigate anti-trans violence.

APA, Harvard, Vancouver, ISO, and other styles

16

Bielecka, Katarzyna. "Transfeminizm(y) – o możliwościach i (granicach) koalicji transfeministycznych." Czas Kultury XXXIX, no. 4 (December 21, 2023): 13–20. http://dx.doi.org/10.61269/svbn2882.

Full text

Abstract:

Transfeminist theory makes it possible to think about trans coalitions beyond the alliance formed within the LGB(T) movement. As many authors argue, transfeminism can provide a bridge between feminist and trans politics. However, visions of this coalition vary depending on both their location and the specific author. Since the term “transfeminism” is not widely used in Poland, the purpose of this article is not only to present major transfeminist texts and authors, but also to structure the application of the term and outline its history. The key organizing question of the article, however, is what projects are being formulated within the framework of transfeminist politics and how do they draw a vision of a transfeminist coalition? Since transfeminism is widely considered to be part of third-wave feminism, the article also aims to identify places where transfeminist theory enters into dialogue (and sometimes conflicts) with feminist theory. Key-words: transfeminism, trans studies, feminism, feminist coalitions

APA, Harvard, Vancouver, ISO, and other styles

17

Angus, Lachlan M., Tina Lin, Shalem Y. Leemaqz, and Ada S. Cheung. "Effect of Feminizing Hormone Therapy on QTc Interval." JAMA Network Open 7, no. 3 (March 28, 2024): e243994. http://dx.doi.org/10.1001/jamanetworkopen.2024.3994.

Full text

Abstract:

This secondary analysis of a randomized clinical trial investigates the effect of spironolactone and cyproterone acetate hormone therapy on the QT interval corrected for heart rate among transgender women and nonbinary or transfeminine individuals.

APA, Harvard, Vancouver, ISO, and other styles

18

Solís Pérez, Marlene, and Guillermo Alonso Meneses. "Un relato femenino de frontera: de la antibiografía a la subjetivación transfemenina = A feminine narrative in the border: From antibiography to transfeminine subjectivation." FEMERIS: Revista Multidisciplinar de Estudios de Género 2, no. 2 (July 31, 2017): 203. http://dx.doi.org/10.20318/femeris.2017.3766.

Full text

Abstract:

Resumen. Este artículo trata sobre la negociación identitaria y los procesos de subjetivación y des-subjetivación. A través de la biografía contracultural o de la adversidad (anti) biográfica de Beatriz, se van desvelando las estrategias de intersección, predominancia, fragmentación y fusión que ella emprendió para conciliar sus múltiples pertenencias, darle significado a su vida y enfrentar las tensiones que le generan las relaciones de poder de las que participa por su condición social, como mujer, madre, esposa, obrera y lesbiana, en una experiencia de transfeminidad.Palabras clave: género, subjetividad femenina, transfeminidad, identidades lésbicas, fronteras simbólicasAbstract. This article is about the identity negotiation processes of subjectivation and de-subjectification. Through the contracultural biography or the (anti)biographical adversity of Beatriz it is uncovered the different strategies of intersection, dominance, fragmentation and merging that she undertook to reconcile their multiple belongings, give meaning to her life and deal with the stresses and contradictions that are generated by her social condition, as a woman, mother, wife, worker and lesbian, in a transfeminity experience.Keywords: gender, female subjectivity, transfeminine, lesbian identity, symbolic boundaries.

APA, Harvard, Vancouver, ISO, and other styles

19

Morse, Nicole Erin. "The Transfeminine Futurity in Knowing Where to Look." TSQ: Transgender Studies Quarterly 6, no. 4 (November 1, 2019): 659–66. http://dx.doi.org/10.1215/23289252-7771810.

Full text

Abstract:

Abstract In this interview, trans artist Vivek Shraya discusses the gendered politics of self-representation, the misogynistic stigma that attaches to her selfies, and the power of controlling the gaze and knowing “where to look.”

APA, Harvard, Vancouver, ISO, and other styles

20

Angus, Lachlan, Shalem Leemaqz, Olivia Ooi, Pauline Cundill, Nicholas Silberstein, Peter Locke, Jeffrey D. Zajac, and Ada S. Cheung. "Cyproterone acetate or spironolactone in lowering testosterone concentrations for transgender individuals receiving oestradiol therapy." Endocrine Connections 8, no. 7 (July 2019): 935–40. http://dx.doi.org/10.1530/ec-19-0272.

Full text

Abstract:

Background Oestradiol with or without an anti-androgen (cyproterone acetate or spironolactone) is commonly prescribed in transfeminine individuals who have not had orchidectomy; however, there is no evidence to guide optimal treatment choice. Objective We aimed to compare add-on cyproterone acetate versus spironolactone in lowering endogenous testosterone concentrations in transfeminine individuals. Design Retrospective cross-sectional study. Methods We analysed 114 transfeminine individuals who had been on oestradiol therapy for >6 months in two gender clinics in Melbourne, Australia. Total testosterone concentrations were compared between three groups; oestradiol alone (n = 21), oestradiol plus cyproterone acetate (n = 21) and oestradiol plus spironolactone (n = 38). Secondary outcomes included serum oestradiol concentration, oestradiol valerate dose, blood pressure, serum potassium, urea and creatinine. Results Median age was 27.0 years (22.5–45.1) and median duration of hormone therapy was 1.5 years (0.9–2.6), which was not different between groups. On univariate analysis, the cyproterone group had significantly lower total testosterone concentrations (0.8 nmol/L (0.6–1.20)) compared with the spironolactone group (2.0 nmol/L (0.9–9.4), P = 0.037) and oestradiol alone group (10.5 nmol/L (4.9–17.2), P < 0.001), which remained significant (P = 0.005) after adjustments for oestradiol concentration, dose and age. Serum urea was higher in the spironolactone group compared with the cyproterone group. No differences were observed in total daily oestradiol dose, blood pressure, serum oestradiol, potassium or creatinine. Conclusions The cyproterone group achieved serum total testosterone concentrations in the female reference range. As spironolactone may cause feminisation without inhibition of steroidogenesis, it is unclear which anti-androgen is more effective at feminisation. Further prospective studies are required.

APA, Harvard, Vancouver, ISO, and other styles

21

Romero, Ronald Gavidia, Hiral Padia, Lisa Matlen, and Shelley Hershner. "0730 Polysomnographic characteristics among transgender adults; Influence of gender-affirming hormone therapy." SLEEP 46, Supplement_1 (May 1, 2023): A321. http://dx.doi.org/10.1093/sleep/zsad077.0730.

Full text

Abstract:

Abstract Introduction Gender differences in polysomnographic characteristics (PC) among cisgender people may be influenced by gonadal hormones. Data on PC among transgender people (TP) receiving or not gender-affirming hormone therapy (GAHT) is sparse. This study aimed to describe PC among TP and explore associations between gender identity (GI), GAHT, and PC. Methods This cross-sectional study identified TP at a large academic sleep medicine center through medical record review. We included TP aged ≥18 years with available polysomnography data. The sample was stratified by GI (transfeminine and transmasculine) and further classified by GAHT use. Descriptive statistics were calculated for GI and GAHT groups. Linear regression models adjusted for age, obstructive sleep apnea, and depression diagnoses were utilized to examine associations between GI, GAHT, and PC (total sleep time [TST], sleep onset latency, rapid eye movement sleep latency [REMSL], arousal index, wake after sleep onset [WASO], sleep stage rapid eye movent [REM], non-REM [N] 1, 2, and 3 percentage, sleep efficiency, and periodic limb movement index [PLMI]). Results Seventy-seven individuals met inclusion criteria. Of these, 52% were transfeminine, mean age was 39.2±13.3 years, mean body mass index was 35.1±9.0 Kg/m2, and 56% used GAHT. Transmasculine people had significantly higher stage N3% (13.9±13.6 vs 7.7±10.0%), and lower PLMI (3.5±5.8 vs 10.6±18.6/h) compared to transfeminine participants. Among transmasculine people, REMSL was shorter in participants using GAHT compared to those not on GAHT (145.0±66.9 vs 217.1±104.1 minutes). In transfeminine people, stage N3% and REMSL were increased in those on GAHT compared to individuals not on GAHT (10.6±11.5 vs 4.9±7.7%; 214.8±126.9 vs 133.6±85.5 minutes, respectively), although not statistically significant. Adjusted analysis showed associations between transmasculine identity and decreased TST (β=-42.8, 95% CI [-84.7, -0.9] minutes), feminizing GAHT use and longer REMSL (β=84.2, 95% CI [0.1, 168.4] minutes), and suggested decreased REMSL and WASO with masculinizing GAHT use (β=-59.4, 95% CI [-134.2,15.3]; β=-28.7, 95% CI [-72.5, 15.0] minutes respectively). Conclusion This report highlights differential associations between GI, GAHT, and PC in TP. Despite some enhanced PC, transmasculine identity significantly decreased TST. In addition, feminizing GAHT contributed to mixed PC outcomes, while masculinizing GAHT appeared to improve them. Support (if any) None

APA, Harvard, Vancouver, ISO, and other styles

22

Hashemi, Leila, Andriana Marijic Buljubasic, Matthew J. Budoff, Laurel A. Copeland, Nicholas J. Jackson, Guneet K. Jasuja, Jeffery Gornbein, and Karen Reue. "Gender-Affirming Hormone Treatment and Metabolic Syndrome Among Transgender Veterans." JAMA Network Open 7, no. 7 (July 2, 2024): e2419696. http://dx.doi.org/10.1001/jamanetworkopen.2024.19696.

Full text

Abstract:

ImportanceGender-affirming hormone treatment (GAHT) is a common therapy for transgender individuals to reduce gender dysphoria and improve quality of life. Clarifying the long-term effects of GAHT remains a priority in transgender health research.ObjectiveTo explore whether sex hormones (estradiol and testosterone) are associated with the development of metabolic syndrome in transgender veterans compared with cisgender veterans.Design, Setting, and ParticipantsThis retrospective, longitudinal cohort study used International Classification of Diseases, Ninth Revision and International Statistical Classification of Diseases and Related Health Problems, Tenth Revision diagnosis codes for gender dysphoria from the Veterans Health Administration national database to identify transfeminine and transmasculine veterans receiving documented feminizing (estradiol) or masculinizing (testosterone) treatment from January 1, 2006, to December 31, 2019, and for whom the GAHT initiation date and metabolic syndrome component–related data were available. Transgender veterans were matched to cisgender referents.ExposureGender-affirming hormone treatment.Main Outcomes and MeasuresMetabolic syndrome z-scores were calculated based on body mass index, systolic blood pressure, and levels of high-density lipoprotein cholesterol, triglycerides, and blood glucose. Changes in mean z-scores were compared among the transgender and cisgender groups before and after the index date (corresponding to GAHT initiation) using a repeated-measures analysis of variance model.ResultsThe cohort included 1290 participants: 645 transgender (494 [38.3%] transfeminine, 151 [11.7%] transmasculine) and 645 cisgender (280 [21.7%] female, 365 [28.3%] male). Mean (SD) age at the index date was 41.3 (13.2) years. Metabolic syndrome z-scores changed significantly over time and differed significantly across groups. Overall, transmasculine veterans had the greatest percentage increase in mean (SEM) z-scores after vs before the index date (298.0% [57.0%]; P &lt; .001), followed by cisgender females (108.3% [27.5%]; P &lt; .001), cisgender males (49.3% [27.5%]; P = .02), and transfeminine persons (3.0% [10.7%]; P = .77).Conclusions and RelevanceIn this cohort study, in both cisgender and transgender veterans, estradiol was associated with reduced metabolic syndrome risk, whereas testosterone was associated with increased risk. However, transmasculine individuals had the greatest risk and transfeminine individuals had the lowest risk of metabolic syndrome associated with these hormones. This is relevant for the management of metabolic syndrome risk factors in cisgender and transgender individuals and to potentially predict the risk of atherosclerotic cardiovascular disease, type 2 diabetes, systolic hypertension, insulin resistance, and nonalcoholic fatty liver disease.

APA, Harvard, Vancouver, ISO, and other styles

23

Bekeny, Jenna C., Elizabeth G. Zolper, Kenneth L. Fan, and Gabriel Del Corral. "Breast augmentation for transfeminine patients: methods, complications, and outcomes." Gland Surgery 9, no. 3 (June 2020): 788–96. http://dx.doi.org/10.21037/gs.2020.03.18.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Mechcatie, Elizabeth, and Karen Rosenberg. "Study Finds Increased Venous Thromboembolism Risk in Transfeminine Patients." AJN, American Journal of Nursing 118, no. 10 (October 2018): 69. http://dx.doi.org/10.1097/01.naj.0000546383.12045.1d.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Chaya, Bachar F., Ricardo Rodriguez Colon, Gustave K. Diep, Hilliard Brydges, David Tran, Matteo Laspro, Ogechukwu C. Onuh, Jorge Trilles, Daniel Boczar, and Eduardo D. Rodriguez. "Comparative Outcomes of Malar Implants Versus Fat Transfer to Cheeks Among Transfeminine Individuals Undergoing Malar Augmentation." Annals of Plastic Surgery 90, no. 6S (June 2023): S457—S461. http://dx.doi.org/10.1097/sap.0000000000003491.

Full text

Abstract:

Background Malar augmentation is a key procedure sought out by transfeminine individuals seeking to feminize their facial appearance. Different surgical techniques have been described in the literature including fat transfer to the cheeks and malar implant placement. Because of the paucity of information in the literature, there is no consensus on best practices for this procedure. The objective of our study is to determine the effectiveness and safety of malar implants as compared with fat transfer to the cheeks in transfeminine individuals. Methods We examined all patients with the diagnosis of gender dysphoria that were referred to the senior author seeking consultation for feminizing facial procedures between June 2017 and August 2022. Patients who underwent fat transfer to the cheeks or malar implant placement were included in our study. We reviewed the electronic medical record of each patient, and we retrieved and analyzed data regarding demographics, medical and surgical history, operative dictations, clinic notes, and postoperative follow-up. Univariate analysis was used to assess for differences in postoperative complications between these 2 groups. Results We identified 231 patients underwent feminizing facial gender affirming surgery, with 152 patients receiving malar augmentation through malar implants or fat grafting. One hundred twenty-nine patients (84.9%) underwent malar implant placement and 23 (15.1%) underwent fat grafting to the cheeks. The mean follow-up time was 3.6 ± 2.7 months. Patient satisfaction was greater in the malar implant group (126/129, 97.7%) compared with the fat transfer group (20/23, 87%, P < 0.045). Two patients who received implants (1.8%) experienced postoperative complications. No patient undergoing fat transfer experiences similar adverse outcomes. Nevertheless, the difference was not statistically significant (P = 1.00). Conclusions Our findings support the contention that malar implants are a safe alternative for malar augmentation among transfeminine individuals. While autologous fat transfer to the cheek is an indispensable option in patients requiring minor malar enhancement, malar implants offer a more permanent option with a better aesthetic outcome in patients requiring major malar enhancement. To minimize postoperative complications, surgeons should emphasize patient compliance with postoperative directions.

APA, Harvard, Vancouver, ISO, and other styles

26

Hojbjerg, Johanne Andersen, Sofia Lisby Saini, Anne-Mette Hvas, and Astrid Ditte Hojgaard. "Current Treatment Regimens for Transfeminine Individuals in the Nordic Countries." Journal of Sexual Medicine 18, no. 3 (March 2021): 656–63. http://dx.doi.org/10.1016/j.jsxm.2020.12.018.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Kozato, Aki, Subha Karim, Sumanth Chennareddy, Uchechukwu O. Amakiri, Jess Ting, Bella K. Avanessian, Joshua D. Safer, James Eckert, Marissa Kent, and John Henry Pang. "Neovaginal Stenosis in Transfeminine Patients after Gender-Affirming Vaginoplasty Operation." Journal of the American College of Surgeons 233, no. 5 (November 2021): S199—S200. http://dx.doi.org/10.1016/j.jamcollsurg.2021.07.406.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Dahl, Kimberly L., and Leslie A. Mahler. "Acoustic Features of Transfeminine Voices and Perceptions of Voice Femininity." Journal of Voice 34, no. 6 (November 2020): 961.e19–961.e26. http://dx.doi.org/10.1016/j.jvoice.2019.05.012.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Kattari, Shanna K., Brittanie Atteberry-Ash, Christopher Collins, Leonardo Kattari, and Vern Harner. "Increased Prevalence, Predictors, and In-Group Differences of Forced Sex and Physical Dating Violence among Trans/Gender Diverse Youth." Social Sciences 10, no. 6 (June 21, 2021): 236. http://dx.doi.org/10.3390/socsci10060236.

Full text

Abstract:

Forced sex and dating violence are too common among young people and rates are higher for young transgender and gender diverse (TGD) individuals. However, the TGD youth population has differential experiences across gender, race, age, sexual orientation, and other identity factors. This study, using data from the 2015 Healthy Kids Colorado Survey, explores these differential within-group experiences of forced sex and dating violence. Findings indicate that sexual minorities who are also TGD are 2.45–3.73 times more likely to experience forced sex and physical dating violence than their TGD heterosexual peers. Individuals who are transfeminine (4.49 times), transmasculine (2.52 times), and nonbinary (3.86 times) are more likely to experience forced sex, as well as physical dating violence (transfeminine (4.01 times), transmasculine (2.91 times), and nonbinary (4.77 times)), as compared to those individuals questioning their gender. Black individuals (3.93 times) and Multiracial individuals (2.39 times) are more likely to experience dating violence than their White counterparts. Age was related to increased experience of forced sex, with individuals being 1.34 times more likely to have experienced this per year increase of age. These findings indicate the need for more trans-inclusive youth programing around sexual violence and dating violence, as well as taking a more intersectional and personalized approach to prevention work.

APA, Harvard, Vancouver, ISO, and other styles

30

Gavidia, Ronald, Galit Levi Dunietz, Lisa Matlen, Shelley Hershner, Daphna Stroumsa, Neeraj Kaplish, and Louise O’Brien. "417 Transgender Hormone Therapy and Sleep-Disordered Breathing." Sleep 44, Supplement_2 (May 1, 2021): A165. http://dx.doi.org/10.1093/sleep/zsab072.416.

Full text

Abstract:

Abstract Introduction Sex hormones may affect human respiration during wakefulness and sleep. Testosterone has been associated with increased obstructive respiratory events contributing to sleep-disordered breathing (SDB) in men, whereas a protective effect against SDB has been attributed to estrogen in women. These associations, primarily observed in cisgender populations, have been rarely examined in transgender individuals on hormone replacement therapy (HRT). The present study investigated associations between HRT and SDB in transgender adults. Methods A chart review of medical records from transgender patients was conducted in a large academic sleep medicine center. Individuals were included if they were at least 18 years old, had one or more sleep complaints, and SDB testing results available. Participants were then stratified by affirmed gender (transmasculine and transfeminine) and by HRT status. We used descriptive statistics procedures to examine differences between gender and HRT groups. Associations between HRT and the apnea-hypopnea index (AHI) were estimated with age-adjusted linear regression models. Results Of the 194 individuals identified, 89 satisfied the inclusion criteria. Nearly half of participants were transmasculine (52%). The mean age was 38±13 years, and mean body mass index was 34.7±9.0 Kg/m2. Approximately 60% of participants were on HRT at the time of SDB evaluation. Transmasculine people who were prescribed testosterone had a significantly increased AHI and lower oxygen nadir in comparison to transmasculine individuals not on testosterone (AHI 36.8±37.8/hour vs.15.3±16.6/hour, p=0.01; oxygen nadir 83.4±8.3% vs. 89.1±2.4%, p=0.001). In contrast, differences between transfeminine people with and without feminizing HRT (androgen blocker + estrogen) were not statistically significant (AHI 21.4±27.7/hour vs. 27.7±26.0/hour, p=0.45; oxygen nadir 86.5±6.7% vs. 84.1±7.7%, p=0.29). Linear regression models adjusted for age found an association between HRT and AHI for transmasculine (β=16.7, 95% CI 2.7, 30.8), but not for transfeminine participants (β=-2.5, 95% CI -17.9, 12.9). Conclusion These findings suggest differential associations between HRT and AHI among transgender individuals, with transmasculine on testosterone having a significant increase in AHI. Prospective studies with large sample sizes are warranted to evaluate these associations. Support (if any) Dr. Gavidia’s work was supported by an NIH/NINDS T32-NS007222 grant

APA, Harvard, Vancouver, ISO, and other styles

31

Bonapace-Potvin, Michelle, Sabrina Bijou-Coulon, Maria Cassandre Medor, Pierre Brassard, and Maud Bélanger. "Incidence of Testicular Cancer in Transfeminine Patients following Vaginoplasty with Orchidectomy." Plastic and Reconstructive Surgery - Global Open 10, no. 4 (April 2022): e4051. http://dx.doi.org/10.1097/gox.0000000000004051.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Harper, Gary W., Riley L. Wagner, Elliot Popoff, Sari L. Reisner, and Laura Jadwin-Cakmak. "Psychological resilience among transfeminine adolescents and emerging adults living with HIV." AIDS 33 (June 2019): S53—S62. http://dx.doi.org/10.1097/qad.0000000000002174.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Scheim, Ayden I., and Greta R. Bauer. "Sexual Inactivity Among Transfeminine Persons: A Canadian Respondent-Driven Sampling Survey." Journal of Sex Research 56, no. 2 (November 30, 2017): 264–71. http://dx.doi.org/10.1080/00224499.2017.1399334.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Esculapio, Alex Nora. "The transfeminine mystique: Transsexual models and the UK press, 1960–71." Critical Studies in Fashion & Beauty 15, no. 1 (June 1, 2024): 23–47. http://dx.doi.org/10.1386/csfb_00072_1.

Full text

Abstract:

The article investigates transgender embodiment, public feelings and (in)visibility in the British press in the 1960s and early 1970s by using the models and performers April Ashley (1935–2021) and Amanda Lear (1939–present) as case studies. Both Ashley and Lear worked as performers at the celebrated Parisian cabaret bar Le Carrousel in the 1950s, and later moved to London independently. Ashley – white, British, working class – enjoyed a successful but brief career as a commercial model that was cut short following her outing by a British tabloid in 1961. Lear – of French and alleged south-east Asian origins – associated herself with the fashionable Chelsea set in London in the 1960s and 1970s. Drawing on press articles, fashion editorials, documentaries and autobiographical writing, in this article, I reconstruct the two models’ career trajectories and examine how the British media constructed Ashley and Lear as both objects of disgust and exotic objects of fascination. In doing so, I critically assess their respective attempts to navigate these public feelings in relation to the politics of (in)visibility in the contemporary British media landscape.

APA, Harvard, Vancouver, ISO, and other styles

35

Kozato, Aki, G. W. Conner Fox, Patrick C. Yong, Sangyoon J. Shin, Bella K. Avanessian, Jess Ting, Yiwei Ling, Subha Karim, Joshua D. Safer, and John Henry Pang. "No Venous Thromboembolism Increase Among Transgender Female Patients Remaining on Estrogen for Gender-Affirming Surgery." Journal of Clinical Endocrinology & Metabolism 106, no. 4 (January 8, 2021): e1586-e1590. http://dx.doi.org/10.1210/clinem/dgaa966.

Full text

Abstract:

Abstract Background Both surgery and exogenous estrogen use are associated with increased risk of venous thromboembolism (VTE). However, it is not known whether estrogen hormone therapy (HT) exacerbates the surgery-associated risk among transgender and gender nonbinary (TGNB) individuals. The lack of published data has contributed to heterogeneity in perioperative protocols regarding estrogen HT administration for TGNB patients undergoing gender-affirming surgery. Methods A single-center retrospective chart review was performed on all TGNB patients who underwent gender-affirming surgery between November 2015 and August 2019. Surgery type, preoperative HT regimen, perioperative HT regimen, VTE prophylaxis management, outcomes, and demographic data were recorded. Results A total of 919 TGNB patients underwent 1858 surgical procedures representing 1396 unique cases, of which 407 cases were transfeminine patients undergoing primary vaginoplasty. Of the latter, 190 cases were performed with estrogen suspended for 1 week prior to surgery, and 212 cases were performed with HT continued throughout. Of all cases, 1 patient presented with VTE, from the cohort of transfeminine patients whose estrogen HT was suspended prior to surgery. No VTE events were noted among those who continued HT. Mean postoperative follow-up was 285 days. Conclusions Perioperative VTE was not a significant risk in a large, homogenously treated cohort of TGNB patients independent of whether HT was suspended or not prior to surgery.

APA, Harvard, Vancouver, ISO, and other styles

36

Ren, Thomas, Andre Galenchik-Chan, Zachary Erlichman, and Aleksandra Krajewski. "Prevalence of Regret in Gender-Affirming Surgery." Annals of Plastic Surgery 92, no. 5 (May 2024): 597–602. http://dx.doi.org/10.1097/sap.0000000000003895.

Full text

Abstract:

Introduction Gender-affirmation surgeries are a rapidly growing set of procedures in the field of plastic surgery. This study is novel in that a thorough analysis has not been performed quantifying, identifying, and recognizing the reasons and factors associated with regret in a largely US population. Methods A systematic review of several databases was conducted. After compiling the articles, we extracted study characteristics. From the data set, weighted proportions were generated and analyzed. Results A total of 24 articles were included in this study, with a population size of 3662 patients. A total of 3673 procedures were conducted in the United States, 514 in European nations, 97 in Asian nations, which included only Thailand, and 19 in South American nations, which included only Brazil. The pooled prevalence of regret was 1.94%. The prevalence of transfeminine regret was 4.0% while the prevalence of transmasculine regret was 0.8%. Conclusions Both transfeminine and transmasculine patients had significantly lower rates of regret in the United States when compared with the rest of the world. Our study largely excluded facial gender-affirming surgeries as most of its articles did not fall into our inclusion search criteria. To our knowledge, this is the most recent review performed on the topic of regret among gender-affirming surgery patients with an emphasis on a US cohort. This analysis can help shed light on better ways to enhance patient selection and surgical experience.

APA, Harvard, Vancouver, ISO, and other styles

37

Wesp, Linda M., and Madeline B. Deutsch. "Hormonal and Surgical Treatment Options for Transgender Women and Transfeminine Spectrum Persons." Psychiatric Clinics of North America 40, no. 1 (March 2017): 99–111. http://dx.doi.org/10.1016/j.psc.2016.10.006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Patel, Viren, Shane D. Morrison, Dev Gujural, and Thomas Satterwhite. "Labial Fat Grafting After Penile Inversion Vaginoplasty." Aesthetic Surgery Journal 41, no. 3 (January 5, 2021): NP55—NP64. http://dx.doi.org/10.1093/asj/sjaa431.

Full text

Abstract:

Abstract Background Penile inversion vaginoplasty (PIV) has become the most commonly performed genital surgery for transfeminine patients. However, patients undergoing this procedure may still require revisions to achieve a satisfactory result. Objectives The authors report on the utilization of autologous fat grafting to the labia majora to improve results after PIV and complications that may predict the need for grafting. Methods A retrospective chart review was conducted of a single surgeon’s patients who underwent PIV between July 2014 and December 2019. Demographic information, operative information, and postoperative outcomes were abstracted from the health records. Wilcoxon rank sum tests and chi-squared test were employed for continuous variables and categorical, respectively. Results A total of 182 transfeminine and gender-diverse patients underwent PIV, with 6 patients (3.3%) eventually undergoing labial fat grafting. The most common indication for labial fat grafting was flattened labia majora (83%). All fat grafting procedures were performed concurrently with other revisions of the vaginoplasty. There were no demographic or medical history differences detected between the fat grafting and non-fat grafting groups. Patients who underwent labial fat grafting were more likely to suffer from introital stenosis (33% vs 6%, P = 0.007) and prolonged granulation tissue greater than 6 weeks after initial vaginoplasty (83% vs 32%; P = 0.01). Conclusions Labial fat grafting is a safe and effective method to address defects in the labia majora after PIV. Prolonged granulation tissue and introital stenosis may predict the need for labial fat grafting, possibly due to increased scarring and contracture at the surgical site. Level of Evidence: 4

APA, Harvard, Vancouver, ISO, and other styles

39

Sackey, Joachim, Michelle DallaPiazza, Sari Bentsianov, and Diana Finkel. "Overweight and Obesity Among Adults Identifying on the Transgender Spectrum in Newark, NJ Between 2018 and 2020: A Retrospective Chart Review." Current Developments in Nutrition 5, Supplement_2 (June 2021): 1244. http://dx.doi.org/10.1093/cdn/nzab055_054.

Full text

Abstract:

Abstract Objectives To assess levels of overweight and obesity among transgender adults receiving care in an academic medical center in Newark, NJ between 2018 and 2020. Methods We performed a retrospective review of electronic medical records of transgender adults (≥18 years) receiving care in an academic medical center in Newark, NJ from 2018 through 2020. We used CDC Body Mass Index (BMI) cut-offs to determine overweight or obesity. Results Of the 159 patients included in this study, the median age was 28 years (range 18–75 years), 47.8% were Black, 27.4% were LatinX and 24.8% were White. Majority (89.3%) were receiving gender-affirming hormones and 69.2% identified as transfeminine. One-third (34.6%) were current smokers, 35.2% had a diagnosis of depression and/or anxiety and 23.3% were living with HIV. BMI was not associated with gender identity, race, hormone use, smoking, HIV status, depression and/or anxiety. A higher proportion of transfeminine participants (31.8%) were HIV positive compared to 4.1% of those identifying as transmasculine. Median BMI of the sample was 26kg/m2, 26.4% were overweight and 32.7% obese. Of the 32.7% who were obese, 12.6% were classified as obesity class 1, 10.7% as obesity class 2, and 9.4% as obesity class 3. Conclusions In this retrospective chart review, almost 60% of all transgender adults were either overweight or obese. Future research is needed to further explore potential clinical implications of elevated weight, as well as the medical, social, psychological, and health behavior factors associated with overweight and obesity among transgender individuals. Funding Sources None.

APA, Harvard, Vancouver, ISO, and other styles

40

Cooper, Holly C., Jin Long, and Tandy Aye. "Fertility preservation in transgender and non-binary adolescents and young adults." PLOS ONE 17, no. 3 (March 11, 2022): e0265043. http://dx.doi.org/10.1371/journal.pone.0265043.

Full text

Abstract:

Although 37.5–51% of transgender adults state they would’ve considered freezing gametes before gender-affirming therapy if offered and 24–25.8% of transgender adolescents express interest in having biological children, less than 5% of transgender adolescents have opted for fertility preservation. We sought to assess fertility preservation utilization in our multidisciplinary adolescent gender clinic. We also aimed to identify fertility preservation utilization and interest among non-binary adolescents and young adults. A retrospective review was conducted of patients seen in the Stanford Pediatric & Adolescent Gender Clinic from October 2015 through March 2019 who were >10 years of age at initial visit. All individuals with documented discussion of fertility preservation were offered referral for formal fertility preservation consultation but only 24% of patients accepted. Only 6.8% of individuals subsequently underwent fertility preservation (n = 9). Transfeminine adolescents are more likely to pursue fertility preservation than transmasculine adolescents (p = 0.01). The rate of fertility preservation in non-binary adolescents did not significantly differ from those in transfeminine adolescents (p = 1.00) or transmasculine adolescents (p = 0.31). Although only one non-binary individual underwent fertility preservation, several more expressed interest with 36% accepting referral (n = 4) and 27% being seen in consultation (n = 3). Despite offering fertility preservation with designated members of a gender clinic team, utilization remains low in transgender adolescents. Additionally, non-binary adolescents and their families are interested in fertility preservation and referrals should be offered to these individuals. Further studies and advocacy are required to continue to address fertility needs of transgender adolescents.

APA, Harvard, Vancouver, ISO, and other styles

41

Cordero, Justin J., Leonardo Alaniz, Sandhya Kalavacherla, Sunil S. Tholpady, and Michael W. Chu. "Trends of Medicare Reimbursement Rates for Gender-Affirming Surgery Procedures." Annals of Plastic Surgery 92, no. 5S (May 2024): S366—S370. http://dx.doi.org/10.1097/sap.0000000000003799.

Full text

Abstract:

Background Awareness of Medicare reimbursement is important for gender-affirming surgeons who treat transgender patients with Medicare. In 2014, Medicare began to provide coverage for medically necessary transition-related surgery. The purpose of this study was to analyze trends in Medicare reimbursement rates for gender-affirming surgery procedures from 2014 to 2022. Methods The Medicare Physician Fee Schedule Look-Up Tool provided by the Centers for Medicare and Medicaid Services was used, and the Current Procedural Terminology codes for 43 gender-affirming surgery services were obtained. Monetary units, conversion factors, relative value units (RVUs) for work, facility, and malpractice costs for 30 transmasculine and 13 transfeminine procedures were analyzed. Descriptive statistics were performed to account for inflation and to determine the relative differences between 2014 and 2022. Results For all gender-affirming surgery procedures covered by Medicare, the average relative difference of monetary units decreased by 2.99% between 2014 and 2022. On average, there was a 3.97% decrease of work-based RVU charges for transmasculine procedures and a 1.73% decrease of work-based RVU charges for transfeminine procedures. After adjusting for inflation, the average relative difference of monetary units for all gender-affirming surgery procedures decreased by 23.42% between 2014 and 2022. Conclusions Reimbursement rates for gender-affirming surgery procedures covered under Medicare have decreased over the observed period, and trends in reimbursement rates have not kept up with consumer price index inflation. Gender-affirming surgeons should be conscious of these changes in reimbursement rates and advocate for fairer compensation to promote medical care among an underserved population.

APA, Harvard, Vancouver, ISO, and other styles

42

Van Gerwen, Olivia T., Zain Aryanpour, John P. Selph, and Christina A. Muzny. "Anatomical and sexual health considerations among transfeminine individuals who have undergone vaginoplasty: A review." International Journal of STD & AIDS 33, no. 2 (October 6, 2021): 106–13. http://dx.doi.org/10.1177/09564624211046997.

Full text

Abstract:

As acceptance of transgender and gender diverse individuals continues to increase, gender-affirming surgery, a cornerstone in the management of gender dysphoria, is becoming more readily available. HIV and sexually transmitted infections (STIs) disproportionately affect these populations, but there are limited epidemiologic and management data on STIs in people who have undergone gender-affirming genital surgery such as vaginoplasty. This review will provide clinicians with anatomical details about the various vaginoplasty procedures currently being performed, complications associated with these procedures, and an overview of the current literature describing HIV/STI epidemiology among transfeminine individuals who have undergone vaginoplasty.

APA, Harvard, Vancouver, ISO, and other styles

43

Hojbjerg, Johanne Andersen, Astrid Ditte Højgaard, and Anne-Mette Hvas. "Biochemical Changes During the First Year of Feminizing Hormone Therapy in Transfeminine Individuals." Sexual Medicine 10, no. 1 (February 2022): 100472. http://dx.doi.org/10.1016/j.esxm.2021.100472.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Kozato, Aki, Subha Karim, Sumanth Chennareddy, Uchechukwu O. Amakiri, Jess Ting, Bella Avanessian, Joshua D. Safer, et al. "Vaginal Stenosis of the Neovagina in Transfeminine Patients after Gender-affirming Vaginoplasty Surgery." Plastic and Reconstructive Surgery - Global Open 9, no. 10S (October 2021): 75. http://dx.doi.org/10.1097/01.gox.0000799480.71688.ab.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Verduzco, Luis A. "Low thoracic erector spinae plane block for perioperative analgesia in transfeminine bottom surgery." Korean Journal of Anesthesiology 73, no. 5 (October 1, 2020): 460–61. http://dx.doi.org/10.4097/kja.20023.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Spencer, Katherine G., and Jennifer A. Vencill. "Body beyond: A pleasure-based, sex-positive group therapy curriculum for transfeminine adults." Psychology of Sexual Orientation and Gender Diversity 4, no. 4 (December 2017): 392–402. http://dx.doi.org/10.1037/sgd0000248.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Klein, Augustus, and Sarit A. Golub. "Increasing Access to Pre-Exposure Prophylaxis Among Transgender Women and Transfeminine Nonbinary Individuals." AIDS Patient Care and STDs 33, no. 6 (June 2019): 262–69. http://dx.doi.org/10.1089/apc.2019.0049.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Ang, Ming Wei, and Gabrielle Ibasco. "The Atemporal Silence of Aesthetics: Transfeminine Crossplay as Resources for Genderqueer Experimentation in Singapore." QED: A Journal in GLBTQ Worldmaking 10, no. 2 (June 1, 2023): 27–49. http://dx.doi.org/10.14321/qed.10.2.0027.

Full text

Abstract:

Abstract This study investigates how transfeminine crossplay—imagined or enacted crossdressing as feminine characters from anime and manga—offers aesthetic resources for genderqueer experimentation. We situate this investigation in Singapore, an Asian sociopolitical context which privileges social harmony and penalizes vocal dissent. Through interviews with six crossplay fans (some identifying as transgender but not others), we unpack how they harness aesthetics in crossplay to negotiate genderqueer trajectories. Crossplay aesthetics clarified gendered feelings and prospective gendered futures. It created gendered-aesthetic styles, forming new trajectories. But for some, it counterproductively constricted gender experimentation's inventiveness. We argue that aesthetic play constitutes a holding space to silently cultivate gender nonconformity, sidestepping Singapore society's demonization of dissent. By momentarily suspending ties to futural demands of gender identities, crossplay installs a sense of atemporality within gendered aesthetics, encouraging fans to engage gender as aesthetic considerations dissociated from personal and social histories of shame, suffering, and discrimination.

APA, Harvard, Vancouver, ISO, and other styles

49

Alba, Brandon, Ian T. Nolan, Brielle Weinstein, and Loren Schechter. "Discussion: Complications following Breast Augmentation in Transfeminine Individuals: A Systematic Review and Meta-Analysis." Plastic & Reconstructive Surgery 153, no. 6 (May 20, 2024): 1252–53. http://dx.doi.org/10.1097/prs.0000000000010922.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Janssen, Diederik F. "Melancholia Scytharum: the early modern psychiatry of transgender identification." History of Psychiatry 32, no. 3 (April 15, 2021): 270–88. http://dx.doi.org/10.1177/0957154x211006253.

Full text

Abstract:

Herodotus’s enigmatic Scythian theleia nousos/morbus femininus and its Hippocratic interpretation interested many early modern authors. Its seeming dimension of transgender identification invited various medico-psychological and psychiatric reflections, culminating in nosologist de Sauvages’ tentative 1731 term, melancholia Scytharum. This article identifies pertinent discussions and what turn out to have been entangled, tentative psychologizations in late-seventeenth through mid-nineteenth-century mental medicine: of ‘effeminacy of manners’ ( mollities animi such as observed in London’s Beaux and mollies) and male homosexuality ( amour antiphysique/grec); of the mental masculinity of some women ( viragines, Amazones); of ubiquitous attributions of impotence to sorcery ( anaphrodisia magica); and lastly, of transfeminine persons encountered throughout the New World and increasingly beyond.

APA, Harvard, Vancouver, ISO, and other styles

Journal articles on the topic 'Transfeminine'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles